Address	130 Eileen Stubbs Avenue Dartmouth Nova Scotia B3B 2C4 Canada
Employees	-
Website	http://www.imv-inc.com
Updated	07/08/2019
IMV, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of cancer immunotherapies and infectious disease vaccines. The firm's patented platform, DepoVax, provides controlled and prolonged exposure of antigens and adjuvant to the immune system. The company was founded by Warwick Kimmins and Brian Lowe on March 28, 2000 and is headquartered in Halifax, Canada.